Your browser doesn't support javascript.
loading
Corrigendum: Aromatase inhibitors: the journey from the state of the art to clinical open questions.
Generali, Daniele; Berardi, Rossana; Caruso, Michele; Cazzaniga, Marina; Garrone, Ornella; Minchella, Ida; Paris, Ida; Pinto, Carmine; De Placido, Sabino.
Afiliación
  • Generali D; Breast Cancer Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.
  • Berardi R; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
  • Caruso M; Medical Oncology, Azienda Ospedaliera Universitaria (AOU) delle Marche, University Politecnica delle Marche, Ancona, Italy.
  • Cazzaniga M; Humanitas Istituto Clinico Catanese, Breast Centre Humanitas Catania, Catania, Italy.
  • Garrone O; School of Medicine and Surgery University of Milano Bicocca, Milan, Italy.
  • Minchella I; Phase 1 Research Unit, Azienda Socio Sanitaria Territoriale (ASST) Monza, Monza, Italy.
  • Paris I; Medical Oncology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Pinto C; Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy.
  • De Placido S; Department of Woman and Child Health and Public Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario Agostino Gemelli Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Front Oncol ; 14: 1369562, 2024.
Article en En | MEDLINE | ID: mdl-38327748
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2023.1249160.].
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia